Medications

What Is Ozempic? Uses, Dosage, Side Effects & What to Expect

GLP-1 Companion · 9 min read

Ozempic has become one of the most recognized prescription drug names in the world. Originally developed and approved for type 2 diabetes, it has captured public attention for its dramatic weight loss effects. But what exactly is Ozempic, how does it work, and is it right for you? This comprehensive guide covers everything you need to know.

What Is Ozempic?

Ozempic is the brand name for semaglutide, a GLP-1 receptor agonist manufactured by Novo Nordisk. It is administered as a once-weekly subcutaneous injection using a pre-filled pen device. The FDA approved Ozempic in December 2017 for the treatment of type 2 diabetes in adults, as an adjunct to diet and exercise to improve glycemic control.

In January 2020, the FDA also approved Ozempic to reduce the risk of major adverse cardiovascular events, including heart attack, stroke, and cardiovascular death, in adults with type 2 diabetes and established cardiovascular disease.

FDA-Approved Uses

• Improving blood sugar control in adults with type 2 diabetes alongside diet and exercise
• Reducing the risk of major cardiovascular events in adults with type 2 diabetes and known heart disease

How Ozempic Works

Ozempic works by mimicking the GLP-1 hormone that your body naturally produces after eating. It activates GLP-1 receptors throughout the body, producing several beneficial effects: it stimulates the pancreas to release insulin when blood sugar is high, suppresses glucagon secretion to prevent excess glucose production by the liver, slows gastric emptying so food moves through the stomach more slowly, and acts on brain centers to reduce appetite and food intake.

Dosing Schedule

Ozempic follows a gradual dose escalation schedule to minimize gastrointestinal side effects. All doses are administered once weekly, on the same day each week, at any time of day, with or without food.

1. Weeks 1-4: 0.25 mg once weekly (initiation dose, not intended for glycemic control)
2. Weeks 5-8: 0.5 mg once weekly
3. Weeks 9+: 1.0 mg once weekly if additional glycemic control is needed
4. Optional: 2.0 mg once weekly for patients requiring further blood sugar reduction

Your doctor may adjust this schedule based on your tolerance and treatment response. If you miss a dose, it can be taken within 5 days of the missed day. If more than 5 days have passed, skip the missed dose and take the next one on the regularly scheduled day.

How to Inject Ozempic

Ozempic comes in a pre-filled, multi-dose pen with a dial to select the correct dose. Injection sites include the abdomen, thigh, or upper arm. You should rotate injection sites with each dose to avoid skin irritation. The needle is very fine (typically 32-gauge), and most patients describe the injection as painless or only mildly uncomfortable.

Common Side Effects

The most common side effects of Ozempic are gastrointestinal and typically occur during dose escalation. They tend to diminish as the body adjusts to the medication.

• Nausea (reported by approximately 20% of patients in clinical trials)
• Diarrhea (approximately 8-9%)
• Vomiting (approximately 5-9%)
• Constipation (approximately 5%)
• Abdominal pain (approximately 5-7%)
• Decreased appetite
• Injection site reactions (redness, itching)

Serious Side Effects (Rare)

While uncommon, serious side effects require immediate medical attention:

• Pancreatitis (severe, persistent abdominal pain that may radiate to the back)
• Gallbladder disease, including gallstones
• Kidney injury, particularly in patients who become dehydrated from vomiting or diarrhea
• Severe allergic reactions
• Changes in vision in patients with diabetic retinopathy
• Thyroid C-cell tumors (observed in rodent studies; relevance to humans is uncertain)

Weight Loss Results with Ozempic

Although Ozempic is approved for diabetes rather than weight loss, clinical trials have documented significant weight reduction. In the SUSTAIN trial program, patients on Ozempic 1.0 mg lost an average of 10 to 14 pounds over 30 to 56 weeks, depending on the study. Patients on the 2.0 mg dose experienced even greater weight loss.

Real-world data suggests that many patients experience weight loss of 10 to 15 percent of their body weight, though individual results vary widely based on factors such as starting weight, diet, physical activity, and adherence to the medication.

It is important to set realistic expectations. Weight loss with Ozempic is gradual and occurs over months, not weeks. Most patients see the largest changes between months 3 and 12 of treatment.

Ozempic vs. Wegovy: What Is the Difference?

Ozempic and Wegovy contain the same active ingredient, semaglutide, and are made by the same manufacturer. The key differences are:

• FDA indication: Ozempic is approved for type 2 diabetes; Wegovy is approved for chronic weight management.
• Maximum dose: Ozempic tops out at 2.0 mg per week; Wegovy goes up to 2.4 mg per week.
• Dose escalation: Wegovy has a more gradual 16-week escalation to the maintenance dose.
• Insurance coverage: Ozempic is more likely to be covered by insurance because it is classified as a diabetes drug.
• Pen devices: The pens are different and not interchangeable between products.

What to Expect When Starting Ozempic

Starting Ozempic is a process, not an event. Here is a general timeline of what many patients experience:

1. Weeks 1-4 (0.25 mg): Minimal effects on appetite or blood sugar. Some mild nausea is possible.
2. Weeks 5-8 (0.5 mg): Appetite reduction becomes noticeable. Blood sugar levels begin to improve. Nausea may increase temporarily.
3. Weeks 9-16 (1.0 mg): Significant appetite suppression and steady blood sugar control. Weight loss becomes more apparent.
4. Months 4-6: Weight loss continues at a steady pace. Side effects usually stabilize or resolve.
5. Months 6-12: Weight loss may slow but continues. Full metabolic benefits become evident in lab results.

Tips for Managing Side Effects

• Eat smaller, more frequent meals instead of large ones.
• Avoid high-fat and greasy foods, which can worsen nausea.
• Stay well hydrated, especially if experiencing vomiting or diarrhea.
• Eat slowly and stop eating when you feel full, even if food remains on your plate.
• Take the injection in the evening if daytime nausea is bothersome.
• Speak with your doctor about delaying dose escalation if side effects are severe.

The Bottom Line

Ozempic is a well-established GLP-1 receptor agonist that effectively improves blood sugar control in type 2 diabetes while also producing meaningful weight loss. Its once-weekly dosing, proven cardiovascular benefits, and extensive clinical track record make it a popular choice for patients and providers alike. If you are considering Ozempic, consult with your healthcare provider to determine whether it fits your medical profile, treatment goals, and insurance coverage.

Sources

• Wilding et al. (2021). Once-Weekly Semaglutide in Adults with Overweight or Obesity. NEJM.
• Ozempic (semaglutide) Prescribing Information. Novo Nordisk.